11 Results for "

ck2+¦-in-1

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "ck2+¦-in-1" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-15260
CAS No.: 1169558-38-6
Purity:  99.76%
Synonyms: BMS-863233
Target:  

CDK

Research Areas:  

Cancer

XL413 is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC50 of 3.4 nM, and also shows potent effect with IC50s of 215, 42 nM on CK2, PIM1, respectively, and an EC50 of 118 nM on pMCM.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-15260A
CAS No.: 2062200-97-7
Purity:  99.65%
Synonyms: BMS-863233 monohydrochloride
Target:  

CDK

Research Areas:  

Cancer

XL413 (BMS-863233) hydrochloride is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC50 of 3.4 nM, and also shows potent effect with IC50s of 215, 42 nM on CK2, PIM1, respectively, and an EC50 of 118 nM on pMCM.
loading...
    loading...
Cat. No.: HY-145260
CAS No.: 2756851-99-5
Purity:  98.21%
BRD4/CK2-IN-1 is the first highly effective and oral active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with IC50s of 180 nM and 230 nM for BRD4 and CK2, respectively. BRD4/CK2-IN-1 has strong anticancer activity without obvious toxicities. BRD4/CK2-IN-1 induces apoptosis and autophagy-associated cell death in triple-negative breast cancer (TNBC)
loading...
    loading...
Cat. No.: HY-149006
CAS No.: 2910938-59-7
Purity:  99.91%
Target:  

DAPK

Research Areas:  

Inflammation/Immunology Cancer

CK156, a chemical probe, is a highly selective death-associated protein kinase (DAPK) inhibitor with IC50s of 182 nM,34 μM, and 39 μM in the DRAK1 NanoBRET assay for DRAK1, CK2a1, and CK2a2, respectively. CK156 can be used for the research of autoimmune and inflammatory diseases .
loading...
    loading...
Cat. No.: HY-156816
CAS No.: 1585246-23-6
Purity:  99.73%
Synonyms: 108600
Research Areas:  

Cancer

ON 108600 (108600) is a CK2 (CK2α1: IC50 = 50 nM; CK2α2 = 5 nM), TNIK (IC50 = 5 nM) and DYRK (DYRK1A: IC50 = 16 nM; DYRK1B = 7 nM; DYRK2: = 28 nM). ON 108600 suppresses the growth of CD44high/CD24low breast cancer stem cell (BCSC) populations, induces G2/M arrest and apoptosis in triple negative breast cancer (TNBC) cells, and inhibits tubulin polymerization. ON 108600 can be used for the study of chemotherapy-resistant and metastatic TNBC .
loading...
    loading...
Cat. No.: HY-148318
CAS No.: 443747-52-2
Purity:  98.34%
Target:  

Casein Kinase

Research Areas:  

Cancer

CK2α-IN-1 (compound 2) is a selective CK2α inhibitor (IC50=7.0 µM; Ki=1.6 µM) that exhibits a non-ATP-competitive mode of action. CK2α-IN-1 exhibits good potential for anticancer studies .
loading...
    loading...
Cat. No.: HY-121792
CAS No.: 51726-83-1
Target:  

Casein Kinase

Research Areas:  

Others

CK2-IN-1 is a CK2 inhibitor, with an IC50 of 150 nM .
loading...
    loading...
Cat. No.: HY-123853
CAS No.: 2101206-81-7
Target:  

Casein Kinase

Research Areas:  

Cancer

CAM4066 is a potent CK2α inhibitor, with an IC50 value of 300 nM. CAM4066 exhibits high selectivity, with IC50 values of 22.35, 43.55, and > 50 μM for HIPK3, DAPK3, and CLK2, respectively. CAM4066 shows no cell activity. CAM4066 can be used for the development of highly potent CK2 inhibitors .
loading...
    loading...
Cat. No.: HY-158371
CAS No.: 2599838-15-8
Target:  

HDAC Casein Kinase

Research Areas:  

Cancer

HDAC/CK2-IN-1 (compound 38) is a HDAC1 (IC50 = 1.46 μM), HDAC6 (IC50 = 0.66 μM), and CK2 (IC50 = 3.67 μM) inhibitor. HDAC/CK2-IN-1 exhibits promising antproliferative activity against Jurkat, MCF-7, HCT-116, and HL-60 cell lines .
loading...
    loading...
Cat. No.: HY-135816
CAS No.: 292640-28-9
Target:  

Casein Kinase Pim

Research Areas:  

Inflammation/Immunology Cancer

CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders .
loading...
    loading...
Cat. No.: HY-117332
CAS No.: 391670-48-7
Synonyms: CGP-029482
Target:  

Casein Kinase

Research Areas:  

Cancer

IQA (CGP-029482) is a potent and selective protein kinase CK2 inhibitor .
loading...
    loading...
  • 1